D1 Receptor Occupancy (RO) Following a Single Dose of PF-06412562
Clinical trial NCT03686501 · COMPLETED
Trial details
- NCT number
- NCT03686501
- Sponsor
- Invicro
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-10
- Primary completion
- 2019-03-28
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.